Teva Reports Positive Phase III Asthma Drug Results

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported that asthma treatment reslizumab demonstrated clear levels of efficacy in achieving the primary endpoint of reduction in the frequency More...